Dengue Seroprevalence and Factors Associated with Dengue Seropositivity in Petaling District, Malaysia.
Malaysia
community-based study
seroepidemiology
tropical disease
vector-borne disease
Journal
International journal of environmental research and public health
ISSN: 1660-4601
Titre abrégé: Int J Environ Res Public Health
Pays: Switzerland
ID NLM: 101238455
Informations de publication
Date de publication:
11 06 2022
11 06 2022
Historique:
received:
11
03
2022
revised:
28
04
2022
accepted:
04
05
2022
entrez:
24
6
2022
pubmed:
25
6
2022
medline:
28
6
2022
Statut:
epublish
Résumé
Dengue virus (DENV) infection is a major public health concern, posing huge economic and disease burdens globally. In Malaysia, the incidence of DENV infections has increased significantly over the years. Nevertheless, the passive surveillance mechanism applied may not capture the actual magnitude of DENV infection. There was also a paucity of community-based studies exploring DENV seroprevalence. This study aimed to determine the DENV seroprevalence and the associated factors among the urban population in Petaling district, Malaysia. A population-based cross-sectional study was conducted from 18 August to 26 October 2018 with 533 participants recruited. Blood samples were collected and analysed for DENV seropositivity using a composite reference standard comprised of three dengue serological tests. Associated factors were identified by fitting Generalised Linear Mixed Models with binomial error structure and logit link function. DENV seroprevalence obtained was 79.0% (95% CI: 75.2-82.4%). The age-specific DENV seroprevalence showed an increasing trend with advancing age, from 22.7% (95% CI: 9.6-45.0%) for those aged below five years old to 94.9% (95% CI: 81.3-98.7%) for those aged ≥60 years old. Only age group and house level were found to be significant factors associated with DENV seropositivity. The odds of being DENV seropositive generally increased with age, from 13.43 (95% CI: 2.77-65.22) for the 5-9 years old age group to 384.77 (95% CI: 39.27-3769.97) for the ≥60 years old age group, as compared to those aged below 5 years old. For house level, those who lived on the first and second floor (OR: 8.98, 95% CI: 3.16-25.12) and the third floor and above (OR: 4.82, 95% CI: 1.89-12.32) had greater odds of being DENV seropositive compared to those living on the ground floor. This study demonstrated the persistently high DENV seroprevalence among the urban population in Petaling district, which could be useful to evaluate dengue control measures taken and estimate more accurate disease incidence. The associated factors with DENV seropositivity identified could also contribute to undertaking more targeted preventive and control measures.
Identifiants
pubmed: 35742419
pii: ijerph19127170
doi: 10.3390/ijerph19127170
pmc: PMC9223214
pii:
doi:
Substances chimiques
Antibodies, Viral
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Références
N Engl J Med. 2019 Nov 21;381(21):2009-2019
pubmed: 31693803
BMC Public Health. 2016 Aug 18;16(1):824
pubmed: 27538986
PLoS Negl Trop Dis. 2018 Nov 2;12(11):e0006932
pubmed: 30388105
Am J Trop Med Hyg. 2015 Jul;93(1):40-45
pubmed: 26013376
Int J Infect Dis. 2020 Feb;91:9-16
pubmed: 31733358
Int J Infect Dis. 2020 Dec;101:90-97
pubmed: 32992011
Ann Acad Med Singap. 2009 Aug;38(8):667-75
pubmed: 19736569
PLoS One. 2015 Dec 14;10(12):e0144451
pubmed: 26656072
PLoS Negl Trop Dis. 2013;7(2):e2055
pubmed: 23437406
Am J Trop Med Hyg. 2014 Nov;91(5):1039-48
pubmed: 25223944
PLoS Negl Trop Dis. 2021 Oct 4;15(10):e0009761
pubmed: 34606516
PLoS Negl Trop Dis. 2017 Jun 15;11(6):e0005621
pubmed: 28617803
Biomed Res Int. 2016;2016:5253842
pubmed: 27446953
PLoS Negl Trop Dis. 2014 May 22;8(5):e2789
pubmed: 24853259
Lancet Glob Health. 2021 Jan;9(1):e44-e51
pubmed: 33212030
BMC Public Health. 2018 Aug 2;18(1):946
pubmed: 30068318
Vet J. 2013 Jan;195(1):33-40
pubmed: 23036176
Infect Dis Poverty. 2018 Jan 16;7(1):1
pubmed: 29335021
Vaccine. 2019 Aug 14;37(35):4848-4849
pubmed: 30424888
BMC Res Notes. 2011 Jun 29;4:216
pubmed: 21714858
Sci Rep. 2020 Jun 12;10(1):9534
pubmed: 32533017
PLoS Negl Trop Dis. 2015 Apr 16;9(4):e0003719
pubmed: 25881272
Int J Environ Res Public Health. 2020 Dec 07;17(23):
pubmed: 33297445
Biosensors (Basel). 2021 Apr 22;11(5):
pubmed: 33921935
Lancet Child Adolesc Health. 2019 Oct;3(10):734-741
pubmed: 31378686
Epidemiol Infect. 2015 Jun;143(8):1585-93
pubmed: 25245094
Trop Med Infect Dis. 2019 Feb 15;4(1):
pubmed: 30781369
PLoS Negl Trop Dis. 2021 Apr 1;15(4):e0009312
pubmed: 33793562
Trop Biomed. 2014 Dec;31(4):698-708
pubmed: 25776595
Epidemics. 2014 Mar;6:30-6
pubmed: 24593919
PLoS Negl Trop Dis. 2014 Nov 06;8(11):e3159
pubmed: 25375211
BMC Infect Dis. 2019 May 20;19(1):441
pubmed: 31109295
Vaccine. 2020 Feb 5;38(6):1363-1369
pubmed: 31879126
Virology (Auckl). 2016 Feb 17;7:1-7
pubmed: 26917954
Med J Malaysia. 2003 Mar;58(1):142-3
pubmed: 14556343
Asian Pac J Trop Med. 2017 Jan;10(1):11-14
pubmed: 28107858
JAMA. 2013 Nov 27;310(20):2191-4
pubmed: 24141714
Trans R Soc Trop Med Hyg. 2020 Nov 6;114(11):798-811
pubmed: 32735681
Pak J Med Sci. 2016 Mar-Apr;32(2):495-8
pubmed: 27182269
Acta Trop. 2019 Sep;197:105066
pubmed: 31226251
PLoS One. 2018 Feb 23;13(2):e0193326
pubmed: 29474401
Euro Surveill. 2010 Sep 30;15(39):19676
pubmed: 20929659
J Immunol Res. 2016;2016:6803098
pubmed: 27525287
Trop Med Health. 2016 Mar 14;44:1
pubmed: 27398060